107000-34-0 Usage
Originator
Zanoterone ,Sterling Drug
(Sanofi-Aventis)
Uses
Anti-androgen.
Manufacturing Process
1). A solution of methanesulfonylhydrazide (0.0303 mole) in tetrahydrofuran
(70 ml, 30 ml for rinsing) was added with stirring to a solution of
(2α,5α,17α)-2-(diethoxymethyl)-17-[(trifluororacetyl)oxy]pregn-20-yn-3-one
(0.025 mole) in tetrahydrofuran (190 ml). The mixture was allowed to stand
for 3 days at room temperature, heated under reflux for 4 h and evaporated.
The residue was purified by crystallization and recrystallization from methanol,
affording (5α,17α)-1'-(methylsulfonyl)-1'H-pregn-20-yno[3,2-c]pyrazol-17-ol
trifluoroacetate (ester), 69% yield, MP: 166°-168°C.
The above ester (10.24 g, 0.0200 mole) in 100 ml of a solution prepared from
chloroform (210 ml), ethanol (100 ml) and concentrated aqueous ammonia
(10 ml) was allowed to stand at room temperature for 2 h, diluted with
chloroform (250 ml), and washed with dilute hydrochloric acid (2 N, 250 ml).
The chloroform layer was dried and removed of chloroform under vacuum. A
solution of the residue in dichloromethane (95 ml) and ether (5 ml) was
passed through silica gel (50 g) using more dichloromethane-ether (19:1, 600
ml). Evaporation of the solvent and recrystallization of the residue from
acetonitrile afforded (5α,17α)-1'-(methylsulfonyl)-1'H-pregn-20-yno[3,2-
c]pyrazol-17-ol (7.07 g, 85% yield, MP: 202°-203°C). It may be also made
another way.2). A solution of methanesulfonylhydrazide (82.5 g, 0.75 mole) in acetic acid
(100 ml) was added with stirring over 5 min to a mixture of (5α,17α)-2-
(acetoxymethylene)-17-hydroxypregn-20-yn-3-one (197 g, 0.51 mole) and
acetic acid (1 L). The mixture was stirred for 1 h at room temperature,
forming a deep yellow solution, which was poured with vigorous stirring into
ice-water (6 L). The resulting solid was collected by filtration, washed twice
with water (500 ml each time), pressed dry, washed twice again with water
(500 ml each time), dried (245 g), recrystallized, first from acetonitrile (2.5
volumes) and then from methanol (6.6 volumes), dried, ground, and redried,
affording (5α,17α)-1'-(methylsulfonyl)-1'-H-pregn-20-yno[3,2-c]pyrazol-17-ol
(137.8 g, 65% yield, MP: 194°-196°C).
Therapeutic Function
Antiandrogen
Check Digit Verification of cas no
The CAS Registry Mumber 107000-34-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,7,0,0 and 0 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 107000-34:
(8*1)+(7*0)+(6*7)+(5*0)+(4*0)+(3*0)+(2*3)+(1*4)=60
60 % 10 = 0
So 107000-34-0 is a valid CAS Registry Number.
InChI:InChI=1/C23H32N2O3S/c1-5-23(26)11-9-19-17-7-6-16-12-20-15(14-25(24-20)29(4,27)28)13-21(16,2)18(17)8-10-22(19,23)3/h1,14,16-19,26H,6-13H2,2-4H3/t16-,17+,18-,19-,21-,22-,23-/m0/s1
107000-34-0Relevant articles and documents
Antiandrogenic steroidal sulfonylpyrazoles
Christiansen,Bell,D'Ambra,Mallamo,Herrmann,Ackerman,Opalka,Kullnig,Winneker,Snyder,Batzold,Schane
, p. 2094 - 2100 (2007/10/02)
The steroidal sulfonylpyrazole 1 bound to the rat ventral prostate androgen receptor in vitro; it inhibited testosterone propionate induced increases in ventral prostate weight in vivo in the castrated, immature male rat with an ED50 of 15 mg/k
Antiandrogenic sulfonylsteroidopyrazoles and processes for preparation method of use and compositions thereof
-
, (2008/06/13)
1''-Sulfonylsteroido[3,2-c]pyrazoles, for example, (5α,17α)-1''-(methylsulfonyl)-1''H-pregn-20-yno[3,2-c]pyrazol-17-ol, which are useful as antiandrogenic agents, and processes for preparation, method of use and compositions thereof are disclosed.
